» Articles » PMID: 26847768

From Competency to Dormancy: a 3D Model to Study Cancer Cells and Drug Responsiveness

Overview
Journal J Transl Med
Publisher Biomed Central
Date 2016 Feb 6
PMID 26847768
Citations 22
Authors
Affiliations
Soon will be listed here.
Abstract

Background: The heterogeneous and dynamic tumor microenvironment has significant impact on cancer cell proliferation, invasion, drug response, and is probably associated with entering dormancy and recurrence. However, these complex settings are hard to recapitulate in vitro.

Methods: In this study, we mimic different restriction forces that tumor cells are exposed to using a physiologically relevant 3D model with tunable mechanical stiffness.

Results: Breast cancer MDA-MB-231, colon cancer HCT-116 and pancreatic cancer CFPAC cells embedded in the stiffer gels exhibit a changed morphology and cluster formation, prolonged doubling time, and a slower metabolism rate, recapitulating the pathway from competency to dormancy. Altering environmental restriction allows them to re-enter and exit dormant conditions and change their sensitivities to drugs such as paclitaxol and gemcitabine. Cells surviving drug treatments can still regain competent growth and form tumors in vivo.

Conclusion: We have successfully developed an in vitro 3D model to mimic the effects of matrix restriction on tumor cells and this high throughput model can be used to study tumor cellular functions and their drug responses in their different states. This all in one platform may aid effective drug development.

Citing Articles

ECM Stiffness-Induced Redox Signaling Enhances Stearoyl Gemcitabine Efficacy in Pancreatic Cancer.

Zhao S, Agyare E, Zhu X, Trevino J, Rogers S, Velazquez-Villarreal E Cancers (Basel). 2025; 17(5).

PMID: 40075719 PMC: 11899364. DOI: 10.3390/cancers17050870.


Dormancy-inducing 3D engineered matrix uncovers mechanosensitive and drug-protective FHL2-p21 signaling axis.

Bakhshandeh S, Heras U, Taieb H, Varadarajan A, Lissek S, Hucker S Sci Adv. 2024; 10(45):eadr3997.

PMID: 39504377 PMC: 11540038. DOI: 10.1126/sciadv.adr3997.


Genistein transfersome-embedded topical delivery system for skin melanoma treatment: and evaluations.

Motawea A, Maria S, Maria D, Jablonski M, Ibrahim M Drug Deliv. 2024; 31(1):2372277.

PMID: 38952058 PMC: 11221477. DOI: 10.1080/10717544.2024.2372277.


Outlook and opportunities for engineered environments of breast cancer dormancy.

Richbourg N, Irakoze N, Kim H, Peyton S Sci Adv. 2024; 10(10):eadl0165.

PMID: 38457510 PMC: 10923521. DOI: 10.1126/sciadv.adl0165.


Breast Cancer Cell Type and Biomechanical Properties of Decellularized Mouse Organs Drives Tumor Cell Colonization.

Pospelov A, Kutova O, Efremov Y, Nekrasova A, Trushina D, Gefter S Cells. 2023; 12(16).

PMID: 37626840 PMC: 10453279. DOI: 10.3390/cells12162030.


References
1.
Erlanson M, Carlsson J . Relations between the penetration, binding and average concentration of cytostatic drugs in human tumour spheroids. Cancer Chemother Pharmacol. 1992; 29(5):343-53. DOI: 10.1007/BF00686002. View

2.
Chaw K, Manimaran M, Tay F, Swaminathan S . Matrigel coated polydimethylsiloxane based microfluidic devices for studying metastatic and non-metastatic cancer cell invasion and migration. Biomed Microdevices. 2007; 9(4):597-602. DOI: 10.1007/s10544-007-9071-5. View

3.
Deryugina E, Quigley J . Matrix metalloproteinases and tumor metastasis. Cancer Metastasis Rev. 2006; 25(1):9-34. DOI: 10.1007/s10555-006-7886-9. View

4.
Nyga A, Cheema U, Loizidou M . 3D tumour models: novel in vitro approaches to cancer studies. J Cell Commun Signal. 2011; 5(3):239-48. PMC: 3145874. DOI: 10.1007/s12079-011-0132-4. View

5.
Erler J, Bennewith K, Nicolau M, Dornhofer N, Kong C, Le Q . Lysyl oxidase is essential for hypoxia-induced metastasis. Nature. 2006; 440(7088):1222-6. DOI: 10.1038/nature04695. View